What's New

  • 30 Sep 2021
    Antares Pharma Initiates Phase I Study for ATRS-1902 for Adrenal Crisis Rescue Read More

  • 08 Sep 2021
    Antares Pharma to Participate in the H.C. Wainright 23rd Annual Global Investment Conference Read More

  • 05 Aug 2021
    Antares Pharma Reports Second Quarter 2021 Financial And Operating Results Read More

$3.4500
$0.0100
0.2907%
Quotes delayed at least 15 minutes